Cardiotoxicities of paclitaxel in African Americans

Journal of the National Medical Association

Volumn 95, Issue 10, 2003, Pages 977-981

  Kamineni, Padma ^b   Prakasa, Kalpana ^b   Hasan, Syed P ^a   Akula, Ravi ^b   Dawkins, Fitzroy ^b  

^a HOWARD UNIVERSITY   (United States)

^b NONE

Author keywords

Arrhythmia; Cardiotoxicities; Paclitaxel

Indexed keywords

PACLITAXEL;

ADULT; AGED; ANEMIA; BRADYCARDIA; CANCER CHEMOTHERAPY; CARDIOTOXICITY; COMORBIDITY; CORONARY ARTERY DISEASE; DEHYDRATION; DOSE RESPONSE; DRUG INFUSION; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE EXTRASYSTOLE; HOSPITAL ADMISSION; HUMAN; HYPOXIA; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEPSIS; SINUS BRADYCARDIA; SINUS TACHYCARDIA; SUPRAVENTRICULAR PREMATURE BEAT; SYMPTOMATOLOGY; T WAVE; TACHYCARDIA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; RISK FACTORS;

EID: 0142031082     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Laher S, Karp SJ. Acute myocardial infarction following paclitaxel administration for ovarian carcinoma. C[in Oncol. 1997;9:124-126.
2. Honda Y, Grube E, De La Fuente LM, Yock PG, Stertzer SH, Fitzgerald PJ. Newer intracoronary stents. Circulation. 2001;104:380-383.
3. Rowinsky EK, McGuire WP, Guarnieri T, Fisherman JS, Christian MC, Donehower RC. Cardiac disturbances during the administration of paclitaxel. J Clin Oncol. 1991;9:1704-1712.
4. Davis SK, Liu Y, Gibbons GH. Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks. Am J Public Health 2003;93:447-455.
5. Anonymous. Paclitaxel. Lancet. 1992;339:1447-1448.
6. Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC. Clinical toxicities encountered with paclitaxel. Semin Oncol. 1993;20 (suppl 3):1-15.
7. McGuire WP, Rowinsky EK, Rosenshein NB, et al. Paclitaxel: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med. 1989:111:273-279
8. Chang AY, Kim K, Glick J, Anderson T, Karp D, Johnson D. Phase-2 study of paclitaxel, merbarone, and piroxantrone in stage-4 non-small-cell lung cancer: the Eastern Cooperative Oncology Group results. J Natl Cancer Inst. 1993;85:388-394.
9. Jekunen A, Heikkila P, Maiche, Pyhonen S. Paclitaxel-induced myocardial damage detected by electron microscopy. Lancet. 1994:343:727-728.
10. Billingham ME. Role of endomyocardial biopsy in diagnosis and treatment of heart disease. In Silver MD, ed. Cardiovascular Pathology: 2nd ed. New York, NY; Churchill Livingstone Inc; 1991:1472-1475.
11. Billingham ME, Bristow MR, Glatstein E, Mason JW, Masek MA, Daniel JR. Adriamycin cardiotoxicity; endomyocardial biopsy evidence of enhancement by radiation. Am J Surg Pathol. 1977;1:17-23.
12. Buja LM, Ferrans VJ, Mayer RJ, Roberts WC, Henderson ES. Cardiac ultrastructural changes induced by daunombicin therapy. Cancer. 1973;32:771-788.
13. Mackay B, Ewer MS, Carrasco CH, Benjamin RS. Assessment of anthracycline cardiomyopathy by endomyocardial biopsy. Ultrastruct Pathol. 1994;18:203-211.
14. Shek TWH, Luk ISC, Ma L, Cheung KL. Paclitaxel-induced cardiotoxicity. Arch Pathol Med. 1996;120:89-91.
15. Cherifi S, Hermans P, Wit SD, Cantinieaux B, Clumeck N. Acute pulmonary hypertension following paclitaxel in a patient with AIDS-related primary effusion lymphoma. Clin Micro & Infect. 2001;7:277.
16. Minotti G, Saponiero A, Licata S, Menna P, Calafiore AM, Teodori G, Gianni L. Paclitaxel and docetaxel enhance the metabolism of doxorubicin to toxic species in human myocardium. Clin Cancer Res. 2001;7:1511-1515.
17. Dinh K, Hasan S. South Med J, Suppl. 2002;95:S5.
18. Drisko JA, Chapman J, Hunter VJ. The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J Am Coll Nutr. 2003;22:118-123.